Assessing Pancreatic Ductal Adenocarcinoma Vascular Invasion: the PDACVI Benchmark
arXiv:2604.27582v1 Announce Type: new
Abstract: Surgical resection remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC), and eligibility depends on accurate assessment of vascular invasion (VI), i.e., tumor exten…